This year around, it seems like Microsoft (NASDAQ MSFT) has a new strategy. It’s a new venture, focused on customer’s fitness regime. This might come as a surprise for many, but Microsoft (NASDAQ MSFT) is launching its new wristband that works in coordination with iOS, Android and Windows phone. The officials at Microsoft (NASDAQ MSFT) said that they are introducing this wearable as a way … Continue reading Microsoft Stock Review (NASDAQ MSFT)
Regeneron and its partner Sanofi announced positive results in the first trial of their extensive Phase III ODYSSEY program (12 trials in total) for alirocumab (REGN-727), which targets PCSK9 to lower LDL (or “bad”) cholesterol. Alirocumab showed a 47.2% reduction in LDL levels from baseline over 24 weeks in patients with primary hypercholesterolemia and moderate cardiovascular risk, compared to 15.6% in patients treated with Zetia … Continue reading Regeneron and Partner Announced Positive First Trial Results of Odyssey
Facebook Inc (NASDAQ FB) is receiving an increasing chunk of brand marketing, especially when it comes to posting and playing videos, says a report from Ad Week. Brands such as Budweiser and McDonald’s and celebrities such as Beyonce are now posting videos directly to the social network instead of just posting YouTube links. YouTube was the first choice of brands for video ads, but now … Continue reading Why has Facebook Video become A Major Trend Among Brands (NASDAQ FB)
I always love to talk about personal finance with my friends and family. And as a wise man once told me 😉, “Personal finance is like a box of chocolates; you never know what you’re going to get.” But recently, the same word keeps coming up repeatedly: “inflation”… A compelling fact is that my $100 bill from three years ago has now shrunk to more … Continue reading Uncertain Times: Navigating the Wild World of Inflation
ResMed delivered another impressive performance in the third quarter of fiscal 2013. Revenue rose 10% to USD 384 million, operating income increased 26% to USD 96.1 million and net income was 31% higher at USD 84.9 million. Diluted earnings per share rose 32% to USD 0.58 and over the nine months to 31 March 2013 are 36% higher than in the corresponding nine months in … Continue reading ResMed Sees Impressive Growth in Q3
PNC Financial Services Group reported net income of $1.1 billion, or $1.99 per diluted share, for second quarter 2013 compared with $1.0 billion or $1.76 per diluted share for first quarter 2013. There were some one-time items, including securities gains ($61 million), gains on sale of Visa V stock ($83 million), and lower loss provision due to the better than expected improvement in commercial credit … Continue reading PNC Poised For Strong Third Quarter
